Announcement of CE-mark for new product: Breast HER2 RoI
We are very proud to announce the CE-mark for another new product: Mindpeak Breast HER2 RoI (Region of Interest) supports pathologists in the scoring of digital images of breast cancer tissue, which underwent immunohistochemical (IHC) staining of the human epidermal growth factor receptor 2 (HER2). The statistical evaluation shows that the agreement rate of nearly 79% when scoring assisted by Mindpeak Breast HER2 RoI is significantly larger than the clinical state-of-the-art agreement rate of 68% when scoring manually. Breast HER2 RoI is the 8th CE-marked product we have launched into the market in the last 14 months.
You may also be interested in
Find out more about our AI-based diagnostics
© 2022 Mindpeak GmbH
Supported by:
